Investigation of MuvB, B-Myb, and FOXM1 targets in breast cancer cells yielded further ties to MMB-regulated kinesins, whereby inhibition of two targets (KIF23 and PRC1) significantly reduced MDA-MB-231 cell proliferation. Here, MYBL2 is linked to breast cancer.